Climatic Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Climatic Inc. - overview
Established
2023
Location
New York, NY, US
Primary Industry
Medical Devices & Equipment
About
Based in the US, Climatic Health operates as a health technology company focused on enhancing respiratory health through innovative products. Climatic Health, founded in 2023 by Allie Melnick and Eric Kau in New York, US, specializes in health technology products aimed at improving lung function. The current CEO is Eric Kau. In 2025, Climatic raised USD 10 million in seed funding led by new investor Lerer Hippeau Ventures, with participation from other new investors BBG Ventures, Brand Foundry Ventures, Cade Ventures Management, Good Friends, and Spacestation Investments.
Climatic Health’s core offering is L Max, a daily lung health system designed to improve respiratory function and athletic performance through scientifically-backed methods. L Max addresses various end-use cases including poor air quality, improved athletic performance, mucus and cough relief, and overall easier breathing for diverse user groups. The product is clinically studied and tested by athletes and field experts, targeting health-conscious consumers and performance-oriented athletes, with a planned launch in Spring 2026. Climatic Health operates on a direct-to-consumer model, generating revenue through subscriptions and sales of its core lung health system.
Clients can join a pre-launch community for early access to products, with transactions likely occurring through online platforms. The structure includes individual pricing plans for their flagship product, L Max, targeting environmental health advocates and athletes seeking performance enhancement. Following the recent SEED funding round, Climatic plans to utilize the USD 10. 00 mn to develop its daily lung health system further, expand research, and grow its team.
The company aims to launch L Max in Spring 2026, with a focus on geographical markets prioritizing lung health and athletic performance, specifically targeting urban areas facing pollution challenges and regions known for outdoor sports activities.
Current Investors
Lerer Hippeau Ventures Management, Brand Foundry Ventures, BBG Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.climatichealth.com/
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.